Why All the Focus on Cardiac Imaging?
Logo - http://photos.prnewswire.com/prnh/20141216/164595LOGO
Changing lifestyles, hectic day-to-day activities and unhealthy eating habits have been on the constant rise over the last decade and directly impacting the health - especially cardiac health - of every individual. These trends are prevalent, though in varied proportion, across the entire world. Developed nations have the highest incidence of cardiovascular diseases and the trend is slowly picking up in developing nations.
Cardiac or cardiovascular imaging refers to a combination of imaging technologies that can be used to obtain images related to the structure and function of the heart. Cardiac imaging has become essential for achieving a better understanding of cardiovascular diseases. Due to the evolution of new technologies and incremental innovation of existing technologies, the role of cardiac imaging has extended into the functional and hemodynamic diagnosis of multiple physiological processes.
The cardiovascular imaging field has experienced marked growth and technology advancement in the past several decades. In the future, it is expected that multimodality imaging will provide enhanced characterization of heart disease states apart from diagnostic imaging. The present and future trends in cardiovascular imaging indicate that cardiac imaging will focus more on improving early diagnosis of cardiac diseases, so as to enable quick clinical decision and early treatment.
What Will You Learn About?
This webinar will explore and analyze the diagnostic cardiac imaging technology trends across the globe and will benefit all value chain participants - from original equipment manufacturers to research centers and universities - as cardiology imaging and diagnosis evolves with time.
Supporting Quote
"The future of cardiac lies in multimodality imaging with the capability to provide enhanced characterization of disease states," said Frost & Sullivan Technical Insights Research Analyst Darshana De. "Single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging of myocardial metabolism and cardiac neuronal imaging has already shown great potential for identifying high-risk patients with coronary heart disease and cardiomyopathy. Clinicians are also looking at a greater use of PET that can be used for quantitative assessment of blood flow as well as for molecular imaging of atherosclerotic plaques and myocardial disease states."
Registration
Supporting Resources
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Contact:
Jennifer Carson
Frost & Sullivan
+1.210.247.2450
[email protected]
